These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 36651792)

  • 1. The rising cost of rhinologic medications.
    Vasudev M; Torabi SJ; Michelle L; Meller LLT; Birkenbeuel JL; Roman KM; Nguyen TV; Kuan EC
    Ann Allergy Asthma Immunol; 2023 Sep; 131(3):327-332. PubMed ID: 37098404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W; Bousquet J; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Wahn U
    Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azelastine/fluticasone and allergic rhinitis in clinical practice.
    Passali D; Passali GC; Damiani V; Ciprandi G
    Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4713-4714. PubMed ID: 37277684
    [No Abstract]   [Full Text] [Related]  

  • 4. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R; Nguyen DT; Kuhl HC
    Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of nasal use of azelastine and mometasone furoate on drug-induced sleep endoscopy.
    Altiner HI; Basal Y; Akyildiz UO
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1423-1432. PubMed ID: 38436176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review.
    Tantilipikorn P; Kirtsreesakul V; Bunnag C; Vangveeravong M; Thanaviratananich S; Chusakul S
    J Asthma Allergy; 2024; 17():667-679. PubMed ID: 39045291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic Rhinitis: A Review.
    Bernstein JA; Bernstein JS; Makol R; Ward S
    JAMA; 2024 Mar; 331(10):866-877. PubMed ID: 38470381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis.
    Samoliński B; Wojas O; Lipiec A; Krzych-Fałta E; Walkiewicz A; Borowicz J; Samoliński K
    Otolaryngol Pol; 2023 Dec; 77(6):43-50. PubMed ID: 38706259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olopatadine/mometasone (Ryaltris) for allergic rhinitis.
    Med Lett Drugs Ther; 2023 Jan; 65(1668):12-14. PubMed ID: 36651792
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison table: Some nasal sprays for allergic rhinitis.
    Med Lett Drugs Ther; 2021 Apr; 63(1622):e66-e71. PubMed ID: 33848283
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs for allergic rhinitis and allergic conjunctivitis.
    Med Lett Drugs Ther; 2021 Apr; 63(1622):57-64. PubMed ID: 33848281
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate.
    Ridolo E; Barone A; Nicoletta F; Paoletti G; Heffler E; Malvezzi L; Canonica GW
    Expert Rev Clin Immunol; 2023 Jun; 19(6):575-584. PubMed ID: 37038974
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.